Pretransplantation monitoring of HLA antibodies by complement dependent cytotoxicity and Luminex-based assays.

Nataša KatalinićMarina FućakTajana CrnićMilena ĆurkovićAlma StarčevićSanja Balen

Published in: Wiener klinische Wochenschrift (2016)

Evaluation of the HLA antibody status in patients on a waiting list for organ transplantation should be based on the results of the both CDC and Luminex® (or other sensitive) assays in accordance to information about patient's clinical status and exposure to immunizing events.

Keyphrases

end stage renal disease
high throughput
newly diagnosed
peritoneal dialysis
healthcare
prognostic factors
case report
mesenchymal stem cells
patient reported outcomes
cell therapy
single cell